Alzheimer disease: MRI and CSF biomarkers in AD-accuracy and temporal change

Nature Reviews Neurology

Volumn 6, Issue 12, 2010, Pages 650-651

  Prins, Niels D ^a   Van Swieten, John C ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; FOLLOW UP; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY OF RESULTS;

EID: 78649952140     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.173     Document Type: Article

References (5)

1. De Meyer, G. et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch. Neurol. 67, 949-956 (2010).
2. Vemuri, P. et al. Serial MRi and CsF biomarkers in normal aging, MCi, and AD. Neurology 75, 143-151 (2010).
3. Jack, C. R. Jr et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128 (2010).
4. Perrin, R. J., Fagan, A. M. & Holtzman, D. M. Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461, 916-922 (2009).
5. Kester, M. I. et al. Diagnostic impact of CsF biomarkers in a local hospital memory clinic. Dement. Geriatr. Cogn. Disord. 29, 491-497 (2010).